About Catalys Pacific
Catalys Pacific is a company based in Cayman Islands founded in 2019. It operates as a Venture Capital and Partnership-based Investment. Catalys Pacific offers products and services including Investment Services and Company Building. Catalys Pacific operates in a competitive market with competitors including Orphalan, Nutrasource, NIMBLE Diagnostics, OneroRx and Droplet, among others.
- Headquarter Cayman Islands
-
Sectors
Financial ServicesHealthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Catalys Pacific
Catalys Pacific offers a comprehensive portfolio of products and services, including Investment Services and Company Building.
Provides funding and support for early-stage biotech startups
Facilitates creation of biotech firms through partnerships
People of Catalys Pacific
Unlock access to complete
Unlock access to complete
Funding Insights of Catalys Pacific
Detailed funding history for Catalys Pacific
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Catalys Pacific
Investment portfolio details for Catalys Pacific
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Catalys Pacific
Detailed financials for Catalys Pacific
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Catalys Pacific Comparisons
Peer comparison for Catalys Pacific
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Catalys Pacific
Catalys Pacific operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orphalan, Nutrasource, NIMBLE Diagnostics, OneroRx and Droplet, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer and provider of access to innovative treatments to patients with rare diseases
|
|
| Locked | Locked | Locked |
Marketing services are provided for healthcare, nutraceutical, and pharmaceutical sectors.
|
|
| Locked | Locked | Locked |
Non-invasive diagnostic devices for cardiovascular stent monitoring are developed.
|
|
| Locked | Locked | Locked |
Telepharmacy services are delivered via an online platform for consultations.
|
|
| Locked | Locked | Locked |
Home pathology samples are collected and diagnostic tests are provided.
|
Detailed competitors of Catalys Pacific
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Catalys Pacific
Complete news archive for Catalys Pacific
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Catalys Pacific
Catalys Pacific was founded in 2019.
Catalys Pacific is headquartered in Cayman Islands.
Catalys Pacific is an investment firm that builds biotech companies by leveraging transpacific partnerships between Japan and the United States. It focuses on accessing early-stage opportunities in areas like hypertension and renal disease treatments. With offices in Tokyo and Seattle, the firm develops therapies to improve patient outcomes while generating returns for investors through strategic investments and local networks.
Catalys Pacific's top competitors include Droplet, Orphalan and PharmaReview.
Catalys Pacific offers Investment Services and Company Building.